Stay updated on IBI310 and Siltilimab in NPC Clinical Trial
Sign up to get notified when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.

Latest updates to the IBI310 and Siltilimab in NPC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedA new platform revision (v3.6.3) was added to the record history, replacing the previous revision (v3.6.0). This update pertains to the page’s versioning metadata rather than study data or participant information.SummaryDifference0.1%

- Check35 days agoChange DetectedThe study record now shows recruitment has ceased for participants. The record version has been updated to v3.6.0, and the previous v3.5.5 revision was removed.SummaryDifference0.4%

- Check42 days agoChange DetectedThe record history shows the revision updated from v3.5.4 to v3.5.5, indicating a new version of the record. This reflects a versioning update rather than substantive changes to the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedA new revision, v3.5.4, is now listed in the Record History, replacing v3.5.3. This update reflects a new release of the study record.SummaryDifference0.1%

- Check86 days agoChange DetectedThe page’s footer/version label updates from Revision v3.5.2 to Revision v3.5.3, reflecting a site release rather than a change to the clinical trial history information.SummaryDifference0.1%

- Check93 days agoChange DetectedAdded Revision: v3.5.2 to the study record history and removed Revision: v3.5.0.SummaryDifference0.1%

Stay in the know with updates to IBI310 and Siltilimab in NPC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 and Siltilimab in NPC Clinical Trial page.